BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8384019)

  • 1. Supraspinal mediation of dopamine-serotonin interactions in extrapyramidal motor functions in the rat.
    Wadenberg ML; Hillegaart V; Berge OG
    Neuroreport; 1993 Jan; 4(1):59-61. PubMed ID: 8384019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for specific interactions between 5-HT1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat.
    Wadenberg ML; Cortizo L; Ahlenius S
    Pharmacol Biochem Behav; 1994 Mar; 47(3):509-13. PubMed ID: 8208768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy.
    Wadenberg ML; Ahlenius S
    J Neural Transm Gen Sect; 1991; 83(1-2):43-53. PubMed ID: 1673344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of median, but not dorsal, raphe 5-HT1A autoreceptors by the local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat.
    Wadenberg ML; Hillegaart V
    Neuropharmacology; 1995 May; 34(5):495-9. PubMed ID: 7566483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.
    Arborelius L; Chergui K; Murase S; Nomikos GG; Höök BB; Chouvet G; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Apr; 347(4):353-62. PubMed ID: 8510763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat.
    Wadenberg ML
    J Neural Transm Gen Sect; 1992; 89(1-2):49-59. PubMed ID: 1418867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P; Chagraoui A; Arbaoui J; Mocaër E
    Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial antagonism of 8-OH-DPAT'S effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist.
    Matuszewich L; Lorrain DS; Trujillo R; Dominguez J; Putnam SK; Hull EM
    Brain Res; 1999 Feb; 820(1-2):55-62. PubMed ID: 10023030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
    Ninan I; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.
    Anderson JJ; Randall S; Chase TN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism by the 5-HT2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat.
    Wadenberg ML; Ahlenius S
    Eur J Pharmacol; 1995 Dec; 294(1):247-51. PubMed ID: 8788438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy.
    Alcock SJ; Hemsley KM; Crocker AD
    Eur J Pharmacol; 2001 Jul; 424(3):179-87. PubMed ID: 11672560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central 5-HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role.
    De Deurwaerdère P; Cervo L; Stinus L; Spampinato U
    Pharmacol Biochem Behav; 2002 Apr; 71(4):627-33. PubMed ID: 11888554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
    Bervoets K; Rivet JM; Millan MJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal monoaminergic modulation of masculine copulatory behavior in the rat.
    Svensson L; Hansen S
    Brain Res; 1984 Jun; 302(2):315-21. PubMed ID: 6145509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
    Papa SM; Engber TM; Boldry RC; Chase TN
    Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.